TW200607863A - Immune modulating compounds from fungi - Google Patents

Immune modulating compounds from fungi

Info

Publication number
TW200607863A
TW200607863A TW094124419A TW94124419A TW200607863A TW 200607863 A TW200607863 A TW 200607863A TW 094124419 A TW094124419 A TW 094124419A TW 94124419 A TW94124419 A TW 94124419A TW 200607863 A TW200607863 A TW 200607863A
Authority
TW
Taiwan
Prior art keywords
compositions
fungi
immune modulating
modulating compounds
immune
Prior art date
Application number
TW094124419A
Other languages
English (en)
Inventor
Bjorn Kristiansen
Original Assignee
Medimush As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/892,393 external-priority patent/US7514085B2/en
Application filed by Medimush As filed Critical Medimush As
Publication of TW200607863A publication Critical patent/TW200607863A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
TW094124419A 2004-07-16 2005-07-19 Immune modulating compounds from fungi TW200607863A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/892,393 US7514085B2 (en) 2004-07-16 2004-07-16 Immune modulating compounds from fungi
US69047705P 2005-06-15 2005-06-15
US69049605P 2005-06-15 2005-06-15
US69048205P 2005-06-15 2005-06-15
DKPA200500882 2005-06-15
DKPA200500881 2005-06-15
DKPA200500880 2005-06-15

Publications (1)

Publication Number Publication Date
TW200607863A true TW200607863A (en) 2006-03-01

Family

ID=35414957

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094124419A TW200607863A (en) 2004-07-16 2005-07-19 Immune modulating compounds from fungi

Country Status (8)

Country Link
EP (1) EP1774012A2 (zh)
JP (3) JP2008525311A (zh)
KR (1) KR20070057803A (zh)
AU (1) AU2005263329A1 (zh)
CA (1) CA2574060C (zh)
IL (1) IL180713A0 (zh)
TW (1) TW200607863A (zh)
WO (1) WO2006007848A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673058B (zh) * 2018-07-20 2019-10-01 金穎生物科技股份有限公司 靈芝複合多醣體組成物

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
EP1896601A1 (en) * 2005-06-15 2008-03-12 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
US9072776B2 (en) 2005-06-15 2015-07-07 Glycanova As Anti-cancer combination treatment and kit-of-parts
KR100825119B1 (ko) * 2006-12-29 2008-04-25 영남대학교 산학협력단 간질환의 예방 또는 치료용 약학조성물
CA2799569A1 (en) * 2009-05-15 2010-11-18 Her Majesty The Queen In Right Of The Province Of Nova Scotia, As Represented By The Nova Scotia Agricultural College (Nsac) On Behalf Of The Minister Of The Agriculture Stable functional beverage compositions and processes for making same
KR101695488B1 (ko) * 2013-12-06 2017-01-23 한명순 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지
WO2015083982A1 (ko) * 2013-12-06 2015-06-11 한명순 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지
US10617697B2 (en) 2015-01-18 2020-04-14 Gavish-Galilee Bio Applications, Ltd. Extracts of edible fungi enriched in vitamin D and compostions thereof and their use in the treatment of immune-related disorders
US20200222536A1 (en) * 2016-05-23 2020-07-16 Orphaderm Limited Biophotonic compositions comprising a fungal-derived chromophore
KR20180093725A (ko) 2017-02-14 2018-08-22 강원대학교산학협력단 렌티난을 함유하는 패혈증의 치료 또는 개선용 약학적 조성물
CN108410944A (zh) * 2018-06-05 2018-08-17 郑州安图生物工程股份有限公司 一种检测艰难梭菌用培养基及其制备方法
CN110403962A (zh) * 2019-09-04 2019-11-05 湖南宇山玉月农业科技有限公司 一种真菌植物在防治鸡坏死性肠炎的应用
CN110656053B (zh) * 2019-11-01 2021-04-13 广东省微生物研究所（广东省微生物分析检测中心） 一种鳞伞属新菌种及其人工栽培方法和用途
FI130808B1 (fi) * 2021-02-19 2024-03-27 Natural Resources Inst Finland Luke Sieniperäinen koostumus, sen tuotantomenetelmä ja käytöt
IT202100029000A1 (it) 2021-11-16 2023-05-16 C I A M S R L Composizioni immunostimolanti per animali da compagnia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572074A (en) * 1977-03-30 1980-07-23 Kirin Seagram Ltd Chemotherapeutic substances and methods of manufacturing same
JPS54148702A (en) * 1978-05-12 1979-11-21 Kirin Brewery Kss22b
JPS5653101A (en) * 1979-09-21 1981-05-12 Kirin Brewery Co Ltd Polysaccharide ks-2-d and its preparation
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
EP0292601A1 (en) * 1987-05-14 1988-11-30 Noda Shokukin Kogyo Co., Ltd. Anti aids drug extracted from lentinus edodes
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
JPH0725802B2 (ja) * 1988-11-28 1995-03-22 味の素株式会社 カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
JP3522772B2 (ja) * 1991-05-21 2004-04-26 台糖株式会社 ワクチンの免疫効果増強剤
JP3651697B2 (ja) * 1995-03-24 2005-05-25 株式会社アミノアップ化学 新規多糖体物質
CN1069650C (zh) * 1995-12-29 2001-08-15 中国科学院上海药物研究所 香菇多糖的分离纯化方法
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
WO2005044182A2 (en) * 2003-09-08 2005-05-19 Genyous Biomed International Inc. Compositions of botanical extracts for cancer therapy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673058B (zh) * 2018-07-20 2019-10-01 金穎生物科技股份有限公司 靈芝複合多醣體組成物
US11191793B2 (en) 2018-07-20 2021-12-07 Geneferm Biotechnology Co., Ltd. Ganoderma lucidum polysaccharides composite composition

Also Published As

Publication number Publication date
WO2006007848A2 (en) 2006-01-26
CA2574060A1 (en) 2006-01-26
JP5926226B2 (ja) 2016-05-25
JP2012017347A (ja) 2012-01-26
JP2008525311A (ja) 2008-07-17
CA2574060C (en) 2019-06-25
IL180713A0 (en) 2007-06-03
EP1774012A2 (en) 2007-04-18
JP2014005307A (ja) 2014-01-16
JP5502830B2 (ja) 2014-05-28
WO2006007848A3 (en) 2006-02-23
KR20070057803A (ko) 2007-06-07
AU2005263329A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
TW200607863A (en) Immune modulating compounds from fungi
TW200720256A (en) IL-12 modulatory compounds
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
TW200628159A (en) IL-12 modulatory compounds
TW200628463A (en) Heteroaryl compounds
TW200514776A (en) Aminotriazole compounds useful as inhibitors of protein kinases
TW200621721A (en) Methods of preparing indazole compounds
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
TWI265927B (en) Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
WO2003027094A3 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
NO20055741D0 (no) Nye kjemiske forbindelser
MY142777A (en) Substituted indole-o-glucosides
MX2007004841A (es) Triazoles utiles como inhibidores de proteinas cinasas.
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
MX2007010045A (es) Pirazolopirimidinas.
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
PL1668001T3 (pl) Podstawione heteroarylobenzofuranowe kwasy
IL144830A0 (en) Ribosomes structure and protein synthesis inhibitors
DE50112128D1 (de) Retardpartikeldispersion
ATE542796T1 (de) N-sulfonylcarboximidamidverbindungen als apoptosepromotoren